Results 121 to 130 of about 5,167,888 (260)

Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2023. [PDF]

Nucleic Acids Res, 2023
CNCB-NGDC Members and Partners.
europepmc   +1 more source

Determining Parental Factors for Clinical Trial Attrition in Pediatric Acute Lymphoblastic Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background/Objectives Despite high enrollment rates on Children's Oncology Group (COG) protocols, attrition after initial consent is challenging, introducing bias and prolonging trial completion. While adult oncology literature has identified predictors of withdrawal, little is known about caregiver decision‐making for child participation in ...
Kimberly L. Stathas, Jakob Q. Weiss, Kellee N. Parker, Cathy Lee‐Miller   +3 more
wiley   +1 more source

Can data center green reform facilitate urban green technology innovation? Evidence from China. [PDF]

Environ Sci Pollut Res Int, 2023
Liu Y, Yang Z.
europepmc   +1 more source

Nephrogenic Rests/Nephroblastomatosis in Patients With Unilateral Wilms Tumor Are Not Associated With an Increased Risk of Relapse: An Analysis of Patients Treated on the SIOP‐WT‐2001 Protocol in the SIOP‐UK‐CCLG and SIOP‐GPOH Studies (2001–2022)

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Nephrogenic rests (NRs) and nephroblastomatosis (NBM) are precursor lesions for development of Wilms tumor (WT). Their association with the risk of relapse has not been properly assessed, partly due to misunderstanding of their diagnostic criteria and terminology.
Gordan M. Vujanić, Rhoikos Furtwängler, Tanzina Chowdhury, Christian Vokuhl, Jenny Wegert, Norbert Graf   +5 more
wiley   +1 more source

Nanosecond optical switching and control system for data center networks. [PDF]

Nat Commun, 2022
Xue X, Calabretta N.
europepmc   +1 more source

Administering Blinatumomab via Continuous Intravenous Infusion in Pediatric Patients—A Single‐Institution Retrospective Review

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab, a CD19xCD3 bispecific T‐cell engager, has become standard therapy for children with de novo B‐cell acute lymphoblastic leukemia (B‐ALL). This retrospective review describes the experience of blinatumomab administration in pediatric patients.
Julia M. Hurley, Ryleigh Krueger, Kellie Joyce, James Stanley, Mary Waskerwitz‐Freyer, Marielle Klunder, David J. Hoogstra   +6 more
wiley   +1 more source

A Multi-Gradient-Descent-Integrated Physics-Informed Autoencoder for Sensor Fault Detection in Data Center Chillers. [PDF]

Sensors (Basel)
Shen X, Li P, Xu C, Xu C.
europepmc   +1 more source

Balanced Energy-Aware and Fault-Tolerant Data Center Scheduling. [PDF]

Sensors (Basel), 2022
Shaukat M, Alasmary W, Alanazi E, Shuja J, Madani SA, Hsu CH.   +5 more
europepmc   +1 more source

Occurrence of Extramedullary Relapses in Pediatric Acute Lymphoblastic Leukemia After Treatment With Blinatumomab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT We report a retrospective single‐center analysis of pediatric patients with relapsed or refractory B‐cell precursor acute lymphoblastic leukemia focusing on relapses outside of the typical locations, bone marrow, central nervous system, or testes.
Johanna Kunz, Martin Ebinger, Michaela Döring, Markus Mezger, Ursula Holzer, Rupert Handgretinger, Peter Lang, Manon Queudeville   +7 more
wiley   +1 more source

Estimating cross-border cloud computing emissions: A consumption-based approach applied to major European data center hubs. [PDF]

iScience
Soares IV, Furberg A, Azizi S, Finnveden G, Yarime M, Klemun MM.   +5 more
europepmc   +1 more source